Body Good Studio
GLP1 EDUCATION

GLP-1 Inhibitors: What They Are and How They Work

Dr. Linda Moleon, MDJune 2, 2026

What Are GLP-1 Inhibitors?

If you've been researching medical weight loss, you've probably heard the term "GLP-1 inhibitors" thrown around — maybe by a friend, a news article, or even your doctor. But here's the thing: the name is technically incorrect. These medications aren't inhibitors at all. They're *agonists*. And while that might sound like semantics, understanding what GLP-1 medications actually do can help you make better decisions about your health.

GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces in your intestines after you eat. It signals fullness, slows digestion, and helps regulate blood sugar. Medications like semaglutide and tirzepatide don't block (inhibit) this hormone — they *mimic* it, which is why they're called GLP-1 receptor agonists. Despite the naming confusion, these medications have become some of the most effective tools for weight loss and metabolic health available today.

Let's clear up the confusion and give you the real information you need.

Why the Term "GLP-1 Inhibitors" Is Misleading

The confusion around "glp 1 inhibitors" likely comes from other classes of medications that *do* use the "inhibitor" label — like ACE inhibitors for blood pressure or proton pump inhibitors for acid reflux. Those medications block or reduce certain processes in your body.

GLP-1 medications work in the opposite way. They *activate* GLP-1 receptors throughout your body — in your pancreas, brain, stomach, and liver — mimicking the natural hormone to produce therapeutic effects. The correct term is GLP-1 receptor agonist, though you'll also see them called GLP-1 analogs or simply GLP-1 medications.

For the rest of this article, we'll use the technically correct terms, but know that when people say "GLP-1 inhibitors," they're usually referring to the same medications.

How GLP-1 Medications Actually Work

GLP-1 receptor agonists work through several interconnected mechanisms:

Appetite Regulation

These medications cross the blood-brain barrier and activate GLP-1 receptors in areas of the brain that control hunger and satiety — particularly the hypothalamus. Most patients report feeling genuinely less hungry, not just "trying harder" to eat less. Food noise quiets. The constant mental negotiation about eating often fades.

Delayed Gastric Emptying

GLP-1 agonists slow the rate at which food leaves your stomach. This means you feel fuller longer after meals. It's also why nausea is a common side effect, especially when starting treatment or increasing doses. If nausea becomes an issue, options like ondansetron anti-nausea can help you stay on track without discontinuing treatment.

Blood Sugar Control

GLP-1 medications stimulate insulin release only when blood sugar is elevated, and they suppress glucagon (a hormone that raises blood sugar). This dual action helps stabilize glucose levels without causing dangerous lows — which is why semaglutide and tirzepatide were originally developed for type 2 diabetes.

Metabolic Benefits Beyond Weight Loss

Emerging research shows GLP-1 agonists may reduce inflammation, improve cardiovascular outcomes, and even protect kidney function. The STEP and SURMOUNT clinical trials demonstrated not just weight loss, but improvements in blood pressure, cholesterol, and markers of metabolic syndrome.

The Most Common GLP-1 Medications

Several GLP-1 receptor agonists are FDA-approved, each with slightly different profiles:

Semaglutide (Ozempic, Wegovy, Rybelsus)

Semaglutide is a once-weekly injectable medication (or daily oral tablet in the case of Rybelsus). Wegovy is FDA-approved specifically for weight loss, while Ozempic is approved for type 2 diabetes but often prescribed off-label for weight management. In the STEP trials, participants lost an average of 15-17% of their body weight over 68 weeks.

Body Good Studio offers compounded semaglutide for adults pursuing medical weight loss under clinician supervision — often at a fraction of the cost of brand-name options.

Tirzepatide (Mounjaro, Zepbound)

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two hormone pathways instead of one. This often translates to greater weight loss — the SURMOUNT-1 trial showed average weight loss of 20-22% over 72 weeks. Like semaglutide, it's a once-weekly injection.

If you're curious but hesitant to commit, Body Good Studio's tirzepatide one-time trial lets you try a single month without long-term commitment.

Liraglutide (Saxenda, Victoza)

Liraglutide is a daily injection and one of the earlier GLP-1 medications approved for weight loss. It's effective but requires daily administration and typically produces more modest weight loss compared to semaglutide and tirzepatide.

Oral GLP-1 Options

For patients who want to avoid injections, oral semaglutide (Rybelsus) is available, though absorption can be variable. Body Good Studio also offers an oral GLP-1 (no commitment) option for adults wanting to try medical weight loss without needles.

Who Should Consider GLP-1 Medications?

GLP-1 receptor agonists are FDA-approved for weight management in adults with:

  • • A body mass index (BMI) of 30 or higher, or

  • • A BMI of 27 or higher with at least one weight-related condition like high blood pressure, type 2 diabetes, or high cholesterol
  • But approval criteria and insurance coverage don't always align. Some insurers cover GLP-1 medications for weight loss; others only cover them for diabetes. If you're unsure whether your insurance will help, Body Good Studio offers a GLP-1 insurance eligibility review — a clinician-supported review of your coverage, BMI eligibility, and prior-authorization pathway.

    You can also check your insurance probability for free using our insurance checker tool before committing to anything.

    What to Expect When Starting GLP-1 Treatment

    The First Few Weeks

    Most protocols start at a low dose and gradually increase every 4 weeks. This "titration" approach minimizes side effects and lets your body adjust. During the first month, you might notice:

  • • Reduced appetite, sometimes dramatically

  • • Mild nausea, especially after eating

  • • Changes in bowel habits (constipation is common)

  • • Increased awareness of portion sizes
  • Side Effects

    The most common side effects are gastrointestinal: nausea, bloating, constipation, and occasionally diarrhea. These usually improve after the first few weeks. Staying hydrated, eating smaller meals, and avoiding high-fat foods can help.

    Rare but serious risks include pancreatitis, gallbladder issues, and thyroid tumors (seen in animal studies but not conclusively in humans). Your clinician will review your full medical history to ensure GLP-1 medications are safe for you.

    Long-Term Use

    GLP-1 medications are not short-term fixes. Most patients continue treatment for months or years. When people stop, appetite and weight often return — which is why these are considered chronic disease treatments, not quick diets.

    How to Access GLP-1 Medications

    There are several pathways:

    Through Insurance

    If you meet BMI and diagnostic criteria, your insurance may cover part or all of the cost — but prior authorization is often required. Navigating this process can be frustrating, which is why clinician support matters.

    Compounded Medications

    When FDA-approved drugs are in shortage (as semaglutide and tirzepatide have been intermittently), the FDA allows compounding pharmacies to produce them. Compounded versions are often much more affordable and are prescribed under the same clinical oversight. Body Good Studio's compounded tirzepatide program is one example.

    Telehealth Platforms

    Many adults now access GLP-1 medications through telehealth platforms like Body Good Studio, which offer:

  • • Licensed clinician consultations (often within 24 hours)

  • • Prescription sent to a licensed pharmacy

  • • Discreet home delivery

  • • Transparent pricing with or without insurance

  • • Ongoing support and monitoring
  • You can explore all of Body Good Studio's medical weight loss programs to see what fits your needs and budget.

    GLP-1 Medications and Lifestyle

    GLP-1 receptor agonists are powerful, but they work best as part of a broader approach. That doesn't mean you need to follow a restrictive diet or spend hours in the gym — but small, sustainable changes amplify results:

  • Prioritize protein: GLP-1 medications reduce appetite, which can make it harder to meet protein needs. Aim for 20-30 grams per meal to preserve muscle mass.

  • Stay hydrated: Slower digestion and reduced thirst signals can lead to dehydration.

  • Move regularly: Even short walks support metabolic health and mood.

  • Work with a clinician: Regular check-ins help you adjust doses, manage side effects, and celebrate progress.
  • Body Good Studio pairs GLP-1 prescriptions with optional nutrition coaching to help you build habits that last.

    Frequently Asked Questions

    Are GLP-1 inhibitors the same as GLP-1 agonists?

    Yes — "GLP-1 inhibitors" is a misnomer. The correct term is GLP-1 receptor agonists (or GLP-1 analogs). These medications activate GLP-1 receptors; they don't inhibit them.

    Can I take GLP-1 medications if I don't have diabetes?

    Yes. Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved for weight management in adults without diabetes, as long as you meet BMI criteria.

    How much weight can I expect to lose on a GLP-1 medication?

    Clinical trials show average weight loss of 15-17% with semaglutide and 20-22% with tirzepatide over 16-18 months. Individual results vary based on dose, adherence, diet, activity, and metabolic factors.

    Do I need to stay on GLP-1 medications forever?

    Many patients continue long-term to maintain weight loss, though some are able to taper off with sustained lifestyle changes. Discuss your goals and timeline with your clinician.

    What if I can't use GLP-1 medications?

    If you have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or certain other conditions, GLP-1 agonists may not be safe. Alternatives include medications like bupropion / naltrexone, which work through different mechanisms.

    The Bottom Line on GLP-1 Inhibitors (Agonists)

    Despite the confusing terminology, GLP-1 receptor agonists represent a major advance in medical weight loss and metabolic health. They're not magic — but for many adults, they make sustainable weight loss achievable in a way that willpower alone never could.

    If you're considering GLP-1 medications, work with a licensed clinician who can assess your eligibility, explain your options (including insurance and compounded medications), and monitor your progress. Telehealth platforms make this easier and more affordable than ever.

    For more information on how these medications work, what to expect, and how to get started, explore more articles on the Body Good Studio blog.

    Ready to Start Your Weight Loss Journey?

    Body Good Studio's clinician-prescribed programs make medical weight loss accessible, affordable, and personalized. Whether you're exploring semaglutide, tirzepatide, or non-GLP-1 options, our licensed clinicians will create a treatment plan that fits your health, budget, and goals. Take our free 60-second quiz to see if you qualify — most members get a treatment plan in under 24 hours.

    Ready to get started?

    Take our quiz to find the perfect program for you.

    Take the Quiz

    Keep reading

    GLP1 EDUCATION

    Tirzepatide Dose: How Dosing Works for Weight Loss

    Tirzepatide dosing starts low and increases gradually over months. Here's exactly how the dose schedule works, what to expect at each level, and how clinicians adjust your protocol.

    GLP1 EDUCATION

    GLP-1: The Complete Guide to How These Medications Work

    GLP-1 medications have transformed medical weight loss. Here's exactly how they work, what to expect, and whether they're right for you — from mechanism of action to real-world results.

    GLP1 EDUCATION

    Wagobi for Weight Loss: What You Need to Know in 2025

    Wagobi is the once-weekly injectable form of semaglutide approved for chronic weight management. Here's how it works, what clinical trials show, and how to access it through insurance or telehealth.

    GLP1 EDUCATION

    Tirzepatide Dosing: A Complete Guide to Safe, Effective Use

    Tirzepatide dosing follows a careful escalation schedule designed to reduce side effects while maximizing weight loss. Here's what the science says—and what your clinician needs you to know.

    GLP1 EDUCATION

    Ozempic for Type 2 Diabetes: What You Need to Know

    Ozempic is FDA-approved to help adults with type 2 diabetes control blood sugar — and it often leads to weight loss. Here's how it works, what to expect, and how to access it through insurance.

    GLP1 EDUCATION

    GLP-1 Agonist: What It Is, How It Works & Who It's For

    GLP-1 agonists are transforming medical weight loss. Here's how these medications work, what to expect, and whether they're right for you — explained by clinicians.